Algo version: 0.98b
EMBC is listed at the NASDAQ Exchange
EMBC [EMBC]
NASDAQ Sector: Healthcare Industry:Drug Manufacturers Specialty Generic

Is EMBC stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Embecta Corp pays dividends. Last time was Friday 13th of September 2024 where the investors holding the stock on Tuesday 27th of August 2024 were paid $0.15000 per share. Over the last 10 times between 2022 and 2024, Embecta Corp has paid $1.5 with an average of $0.15 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Embecta Corp 10 years ago, but if you had invested on Tuesday 22nd of March 2022 when the price was $47.00, you would have made a loss of $-33.37 per share or -71.00%

Yes, the average daily trading liquidity for Embecta Corp is $5.44 million. You should therefore be able to get in and out of your positions relatively fast.

Embecta Corp has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.02, the company's ability to pay off the debt is limited. Embecta Corp has a good net profit margin of 6.23% and should have high tolerances against inflation.

We have calculated the inflation risk for Embecta Corp to be medium [0.7 out of 1]